MKA.L vs. CRVS
MKA.L (Mkango Resources Ltd) and CRVS (Corvus Pharmaceuticals, Inc.) are both stocks. MKA.L operates in Other Industrial Metals & Mining (Basic Materials), while CRVS operates in Biotechnology (Healthcare). Over the past 5 years, MKA.L returned 6.26%/yr vs 33.42%/yr for CRVS. At a 0.01 correlation, their price movements are largely independent.
Performance
MKA.L vs. CRVS - Performance Comparison
Loading charts...
Different Trading Currencies
MKA.L is traded in GBp, while CRVS is traded in USD. To make them comparable, the CRVS values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, MKA.L achieves a -9.68% return, which is significantly lower than CRVS's 46.22% return.
MKA.L
- 1D
- 2.44%
- 1M
- -5.62%
- YTD
- -9.68%
- 6M
- -16.00%
- 1Y
- 150.75%
- 3Y*
- 57.50%
- 5Y*
- 6.26%
- 10Y*
- —
CRVS
- 1D
- 0.24%
- 1M
- -26.74%
- YTD
- 46.22%
- 6M
- 30.04%
- 1Y
- 189.07%
- 3Y*
- 43.18%
- 5Y*
- 33.42%
- 10Y*
- -0.74%
MKA.L vs. CRVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MKA.L Mkango Resources Ltd | -9.68% | 484.91% | -30.87% | -6.12% | -60.48% | 77.14% | 103.49% | -0.00% | 18.62% | 123.08% |
CRVS Corvus Pharmaceuticals, Inc. | 46.22% | 33.67% | 209.29% | 96.71% | -60.54% | -31.66% | -36.48% | 42.59% | -62.47% | -33.82% |
Correlation
The correlation between MKA.L and CRVS is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.01 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.01 |
Correlation (All Time) Calculated using the full available price history since Jun 16, 2016 | 0.01 |
Fundamentals
MKA.L:
£146.26M
CRVS:
$1.00B
MKA.L:
-£0.04
CRVS:
-$0.53
MKA.L:
£50.78K
CRVS:
$0.00
MKA.L:
-£544.15K
CRVS:
-$26.00K
MKA.L:
-£17.87M
CRVS:
-$47.43M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MKA.L vs. CRVS — Risk / Return Rank
MKA.L
CRVS
MKA.L vs. CRVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Mkango Resources Ltd (MKA.L) and Corvus Pharmaceuticals, Inc. (CRVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MKA.L | CRVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.51 | ||
| Sortino ratioReturn per unit of downside risk | -1.71 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.49 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | 2.91 | 3.40 | -0.49 |
| Martin ratioReturn relative to average drawdown | 5.97 | 7.58 | -1.61 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MKA.L | CRVS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.57 | 1.06 | +0.51 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.08 | 0.26 | -0.18 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | -0.01 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.28 | -0.02 | +0.29 |
Drawdowns
MKA.L vs. CRVS - Drawdown Comparison
The maximum MKA.L drawdown since its inception was -88.80%, smaller than the maximum CRVS drawdown of -96.91%. Use the drawdown chart below to compare losses from any high point for MKA.L and CRVS.
Loading charts...
Drawdown Indicators
| MKA.L | CRVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -88.80% | -96.91% | +8.11% |
Max Drawdown (1Y)Largest decline over 1 year | -51.45% | -55.90% | +4.45% |
Max Drawdown (3Y)Largest decline over 3 years | -67.06% | -70.28% | +3.22% |
Max Drawdown (5Y)Largest decline over 5 years | -88.80% | -91.59% | +2.79% |
Max Drawdown (10Y)Largest decline over 10 years | — | -96.91% | — |
Current DrawdownCurrent decline from peak | -39.13% | -55.79% | +16.66% |
Average DrawdownAverage peak-to-trough decline | -43.11% | -70.05% | +26.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.13% | 25.06% | +0.07% |
Volatility
MKA.L vs. CRVS - Volatility Comparison
Mkango Resources Ltd (MKA.L) and Corvus Pharmaceuticals, Inc. (CRVS) have volatilities of 22.49% and 22.62%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MKA.L | CRVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.49% | 22.62% | -0.13% |
Volatility (6M)Calculated over the trailing 6-month period | 48.26% | 110.90% | -62.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 95.38% | 179.36% | -83.98% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.48% | 130.34% | -52.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 96.06% | 110.72% | -14.66% |
Dividends
MKA.L vs. CRVS - Dividend Comparison
Neither MKA.L nor CRVS has paid dividends to shareholders.
Financials
MKA.L vs. CRVS - Financials Comparison
This section allows you to compare key financial metrics between Mkango Resources Ltd and Corvus Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MKA.L and CRVS have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for MKA.L and CRVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer